Cory Renauer
Cory Renauer is a contributing Healthcare Analyst at The Motley Fool, covering publicly traded companies across pharmaceuticals, biotechnology, and medical devices. Prior to The Motley Fool, Cory was an educator in Thailand and a laboratory technician for the American Red Cross. He holds a B.S. in Biology from Oakland University. Fun fact: Cory has a collection of novelty socks featuring famous stock market symbols and iconic investor quotes.
Recent Articles by Cory Renauer

Dec 30, 2023
by Cory Renauer
2 Ultra-High-Yield Dividend Stocks Billionaires Are Buying Left and Right. Could They Be Smart Buys for You in 2024?
Unusually high dividend yields are typically a sign of trouble ahead, but billionaire investors are eager to buy these stocks, according to their latest disclosures.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.